Skip to content

Crypto community with 74% historical accuracy sets XRP price for March 31, 2022

Crypto community with 74% historical accuracy sets XRP price for March 31, 2022

Ripple’s XRP, the sixth-ranked cryptocurrency in terms of market capitalization, is experiencing turbulent times as the blockchain company wages a legal battle with the Securities and Exchange Commission (SEC).

Although XRP’s performance has been flat, significant investors continue to purchase the asset. Indeed, 100 million XRP worth just over $76 million was sent from Crypto.com exchange to an unmarked wallet, according to transaction data from WhaleAlert.

It’s also particularly noteworthy that according to statistics from WhaleStatsBSC, as of March 16, Ripple is one of the most often utilized smart contracts by 1,000 of the largest Binance Smart Chain (BSC) whales during the previous 24 hours.

Given the latest developments around the digital asset’s current situation, the cryptocurrency community at CoinMarketCap has predicted that XRP will trade at $0.83 by the end of March.

The set price represents a 10.82% or $0.08 increase from its current price, which at press time amounted to $0.75. In total, the price estimate included votes from around 3,710 members of the CoinMarketCap community as of March 15.

Crypto community’s XRP price projection. Source: CoinMarketCap

It’s noteworthy that the crypto community currently has a historical accuracy of 73.94% on XRP price projections.

Crypto community’s XRP price prediction historical accuracy rate. Source: CoinMarketCap

At the time of publication, XRP was trading up 1.3% across the previous week with a total market cap of $37.2 billion.

XRP 7-day price chart. Source: CoinMarketCap

Ripple’s saga with the SEC 

As Finbold reported earlier, the blockchain payment company expects the litigation to drag on no longer than the second half of November 2022, putting its expectations somewhere between August 26 and November 18, according to a court document requesting the rescheduling of the pending class action.

The SEC had filed a lawsuit against Ripple and two of its executives in December 2022; it alleges that the blockchain company had sold its token as an investment product without SEC registration from 2013 to December 2020 – when the SEC sued. 

Ripple has argued that the XRP token was a digital asset for real-time global payments and wasn’t subject to SEC’s jurisdiction. 

Recently, its general counsel has accused the agency of using the newest evidence of the company’s proactive compliance “as a sword, or as a bludgeon.”

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.